OLGA ESTEROV: Open Payments
NPI 1568637411 · SHREWSBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,106 in 178 payments from 10 companies in 2025. Trend: 2023 $1,598 · 2024 $2,415 · 2025 $3,106
Food & beverage: $2,994Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $762 |
| ABBVIE INC. | 50 | $605 |
| Axsome Therapeutics, Inc. | 17 | $447 |
| Otsuka America Pharmaceutical, Inc. | 29 | $423 |
| Teva Pharmaceuticals USA, Inc. | 15 | $315 |
| Lundbeck LLC | 17 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $186 |
| Alkermes, Inc. | 10 | $148 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, AUSTEDO XR, TRINTELLIX, LYBALVI, ARISTADA.
Industry payments across NJ — which companies pay providers there.
